πŸ‡ΊπŸ‡Έ FDA
Patent

US 9339469

R(+)-N-methyl-propargyl-aminoindan

granted A61KA61K31/135A61K9/2013

Quick answer

US patent 9339469 (R(+)-N-methyl-propargyl-aminoindan) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/135, A61K9/2013, A61K9/2018, A61K9/2059